Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain

被引:20
作者
Chan, Conrad En Zuo [1 ,2 ]
Lim, Angeline Pei Chiew [1 ]
Chan, Annie Hoi Yi [1 ]
MacAry, Paul A. [2 ]
Hanson, Brendon John [1 ]
机构
[1] DSO Natl Labs, Def Med & Environm Res Inst, Med Countermeasures Biol Lab, Singapore, Singapore
[2] Natl Univ Singapore, Program Immunol, Dept Microbiol, Singapore 117548, Singapore
关键词
ESCHERICHIA-COLI; CARBOHYDRATE STRUCTURE; EFFECTOR FUNCTIONS; GLYCOSYLATION; CYTOPLASM; FRAGMENT; MUTANTS; LEVEL; CELLS;
D O I
10.1371/journal.pone.0010261
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multi-polypeptide proteins such as antibodies are difficult to express in prokaryotic systems such as E. coli due to the complexity of protein folding plus secretion. Thus far, proprietary strains or fermenter cultures have been required for appreciable yields. Previous studies have shown that expression of heterologous proteins in E. coli can be enhanced by the reduction of protein translation rates. In this paper, we demonstrate that useful quantities of full-length IgG can be expressed and purified from the common E. coli laboratory strain HB2151 in standard shaking culture using a simple strategy of reduced inducer concentration combined with delayed induction times to modulate translation rates. Purified IgG had only marginally reduced avidity compared to mammalian derived IgG. This indicates that this technique can be used to derive antibodies of potentially equal utility as those expressed in mammalian cell culture, particularly for applications where effector functions mediated by the glycosylated residues in the Fragment Crystallizable (Fc) portion of the immunoglobulin are not required.
引用
收藏
页数:8
相关论文
共 16 条
[1]   Therapeutic antibody expression technology [J].
Chadd, HE ;
Chamow, SM .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :188-194
[2]   Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor [J].
Ehrt, S ;
Guo, XZV ;
Hickey, CM ;
Ryou, M ;
Monteleone, M ;
Riley, LW ;
Schnappinger, D .
NUCLEIC ACIDS RESEARCH, 2005, 33 (02) :e21
[3]   Glycosylation of recombinant antibody therapeutics [J].
Jefferis, R .
BIOTECHNOLOGY PROGRESS, 2005, 21 (01) :11-16
[4]   IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation [J].
Jefferis, R ;
Lund, J ;
Pound, JD .
IMMUNOLOGICAL REVIEWS, 1998, 163 :59-76
[5]   Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones [J].
Levy, R ;
Weiss, R ;
Chen, G ;
Iverson, BL ;
Georgiou, G .
PROTEIN EXPRESSION AND PURIFICATION, 2001, 23 (02) :338-347
[6]   Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I-1-I-2 regulatory elements [J].
Lutz, R ;
Bujard, H .
NUCLEIC ACIDS RESEARCH, 1997, 25 (06) :1203-1210
[7]   Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli [J].
Mazor, Yariv ;
Van Blarcom, Thomas ;
Mabry, Robert ;
Iverson, Brent L. ;
Georgiou, George .
NATURE BIOTECHNOLOGY, 2007, 25 (05) :563-565
[8]   Engineering of therapeutic antibodies to minimize immunogenicity and optimize function [J].
Presta, Leonard G. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (5-6) :640-656
[9]   Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli [J].
Simmons, LC ;
Yansura, DG .
NATURE BIOTECHNOLOGY, 1996, 14 (05) :629-634
[10]   Expression of full-length immunoglobulins in Escherichia coli:: rapid and efficient production of aglycosylated antibodies [J].
Simmons, LC ;
Reilly, D ;
Klimowski, L ;
Raju, TS ;
Meng, G ;
Sims, P ;
Hong, K ;
Shields, RL ;
Damico, LA ;
Rancatore, P ;
Yansura, DG .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 263 (1-2) :133-147